The early expansion of anergic NKG2A<sup>pos</sup>/CD56<sup>dim</sup>/CD16<sup>neg</sup> natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation

Alessandra Roberto(Humanitas University), Domenico Mavilio(Humanitas University), Luca Castagna(Humanitas University), Jacopo Mariotti(Istituti di Ricovero e Cura a Carattere Scientifico), Elena Tenedini(University of Modena and Reggio Emilia), Enrico Lugli(Humanitas University), Stéfania Bramanti(Istituti di Ricovero e Cura a Carattere Scientifico), Paolo Tentorio(Humanitas University), Emanuela Marcenaro(Azienda Ospedaliera S.Maria), Silvio Bicciato(University of Modena and Reggio Emilia), Emilia Maria Cristina Mazza(University of Modena and Reggio Emilia), Enrico Tagliafico(University of Modena and Reggio Emilia), Clara Di Vito(University of Milan), Barbara Sarina(IRCCS Humanitas Research Hospital), Arianna Capucetti(Università della Svizzera italiana), Elisa Zaghi(Humanitas University), Mario Roederer(National Institutes of Health), Veronica Zanon(Humanitas University), Armando Santoro(IRCCS Humanitas Research Hospital), Michela Calvi(University of Milan)
Haematologica
April 26, 2018
Cited by 68


Related Papers